Astera Labs, Inc. Common Stock (ALAB) vs Nebius Group N.V. (NBIS)
A side-by-side comparison of Astera Labs, Inc. Common Stock and Nebius Group N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
ALAB
Astera Labs, Inc. Common Stock
$260.23TechnologyDelayed quote: Jul 28, 2026, 4:00 PM EDT
NBIS
Nebius Group N.V.
$169.69TechnologyDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — ALAB vs NBIS
growth of $100 · dividends reinvested · last 2yALAB +320.5%NBIS +839.4%NBIS compounded faster
ALAB NBIS
ALAB vs NBIS: by the numbers
- •ALAB is the larger company ($44.61B vs $40.73B market cap).
- •NBIS trades at the lower trailing earnings multiple (62.63 vs 190.89 P/E), one valuation lens rather than an overall verdict.
- •NBIS converts more revenue to profit (95.27% vs 26.72% net margin).
Metrics side by side
Valuation
| Metric | ALAB | NBIS |
|---|---|---|
| P/E ratio | 190.89 | 62.63 |
| Forward P/E | 93.52 | N/A |
| P/S ratio | 51.11 | 66.12 |
| P/B ratio | 34.26 | 8.02 |
| EV / EBITDA | 218.81 | N/A |
| FCF yield | 0.67% | N/A |
Profitability
| Metric | ALAB | NBIS |
|---|---|---|
| Gross margin | 75.99% | 68.63% |
| Operating margin | 22.36% | -112.53% |
| Net margin | 26.72% | 95.27% |
| ROE | 17.91% | 11.55% |
| ROIC | 12.40% | -4.75% |
Growth (annualized)
| Metric | ALAB | NBIS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -23.11% |
| EPS CAGR (5Y) | N/A | -35.43% |
Frequently asked
- Which has the lower trailing P/E, ALAB or NBIS?
- NBIS has the lower trailing P/E: ALAB trades at 190.89 and NBIS at 62.63. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Is ALAB or NBIS more profitable?
- NBIS runs the higher net margin — ALAB at 26.72% versus NBIS at 95.27%.
Go deeper
Dig into the metrics
Astera Labs, Inc. Common Stock P/E ratioNebius P/E ratioAstera Labs, Inc. Common Stock dividend yieldNebius dividend yieldAstera Labs, Inc. Common Stock ROENebius ROEAstera Labs, Inc. Common Stock operating marginNebius operating marginAstera Labs, Inc. Common Stock revenue growthNebius revenue growthAstera Labs, Inc. Common Stock free cash flowNebius free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.